Abstract
The choice of a Phase I contract research organization is clearly a key point for a successful strategy at this early stage of development. A survey was performed with the help of a questionnaire filled in by 36 pharmaceutical companies operating in France and sponsoring Phase I trials.
This survey addressed the following main questions: number and type of Phase I studies, information on Phase I centers, and criteria of choice for a Phase I center. Finally, the answers were compared to a similar survey performed five years earlier.
Get full access to this article
View all access options for this article.
References
1.Scrip Magazine. March 1994 :32 –34 ,.
2.
Püchler
K
Witte
PU
The German CRO market . App Clin Trials.
1996 ;6 (8 ):24 –28 .
3.
Hughes
G.
Criteria for choice of Phase I contract research organizations by pharmaceutical companies . Clin Trials Meta-Analysis.
1994 ;29 (4 ):288 .
4.
Rosenzweig
P
Bergougnan
L
Brohier
S
Les centres de Phase I: le point de vue de l'industriel . La Lett Pharmacol.
1991 ;5 (7 ):248 –252 .
5.
Vogel
JR
Resnich
N.
A case study in evaluating and selecting a CRO . App Clin Trials.
1996 ;6 (8 ):30 –36 .
6.
Schanlder
M.
A strategic role for CROs . App Clin Trials.
1994 ;3 (9 ):56 –64 .